MURALI CHINTAGUMPALA to MutL Protein Homolog 1
This is a "connection" page, showing publications MURALI CHINTAGUMPALA has written about MutL Protein Homolog 1.
Connection Strength
0.066
-
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group. J Neurooncol. 2006 Apr; 77(2):193-8.
Score: 0.066
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.